Healthcare · Diagnostics Research · NASDAQ
| Market cap | $28.38B |
|---|---|
| Trailing P/E | 36.5 |
| FCF yield | 3.2% |
| Revenue growth (YoY) | -0.7% |
| EPS growth (YoY) | +98.0% |
| FCF/share growth (YoY) | +33.8% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Illumina, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Mar 6, 2026 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 1, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 1, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Aug 13, 2025 |
| Michael C. Burgess | House | Sell | $15,001 | Sep 5, 2024 |
| Michael C. Burgess | House | Sell | $15,001 | Sep 3, 2024 |
| Thomas H. Kean | House | Buy | $1,001 - $15,000 | May 2, 2024 |
| Michael C. Burgess | House | Buy | $15,001 - $50,000 | Feb 14, 2024 |
| Kathy Manning | House | Sell | $15,001 - $50,000 | Jul 5, 2022 |
| Donald Sternoff Beyer | House | Sell | $15,001 - $50,000 | Mar 1, 2022 |
| Kathy Manning | House | Buy | $1,001 - $15,000 | Feb 9, 2022 |
| Kathy Manning | House | Buy | $1,001 - $15,000 | Feb 9, 2022 |